(160 days)
No
The device description details a purely mechanical and chemical process for cold therapy. There is no mention of any computational or data-driven components that would indicate the use of AI or ML.
Yes
The device is described as "a single use device for the treatment of hemorrhoids by applying it directly to the swollen hemorrhoidal tissues." The description also details how it "provides targeted cold therapy to the hemorrhoids," indicating its therapeutic purpose.
No
The device description clearly states "Instalief™ is a device designed for the treatment of internal and external hemorrhoids". It applies cold therapy to reduce inflammation, which is a therapeutic action, not a diagnostic one.
No
The device description clearly outlines physical components including bags, salts, water, an insertion tip, a balloon, and a squeezer, indicating it is a hardware-based medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the treatment of hemorrhoids by applying cold therapy. This is a therapeutic intervention, not a diagnostic test performed in vitro (outside the body) on biological samples to diagnose a condition.
- Device Description: The device description details a mechanism for generating and applying cold directly to tissue. It does not involve the analysis of biological samples like blood, urine, or tissue biopsies.
- Lack of IVD Characteristics: There is no mention of reagents, calibrators, controls, or any other components typically associated with in vitro diagnostic tests. The performance studies focus on physical properties, cold duration, and biocompatibility, not diagnostic accuracy metrics like sensitivity, specificity, or AUC.
In summary, Instalief is a therapeutic device for treating a physical condition, not a diagnostic device for identifying a condition through laboratory analysis.
N/A
Intended Use / Indications for Use
Instalief is a single use device for the treatment of hemorrhoids by applying it directly to the sworthoidal tissues. By applying cold to the tissue, the inflammation is reduced. The device can be used for the treatment of external hemorrhoids and internal hemorrhoids. The device is for adults only.
Product codes (comma separated list FDA assigned to the subject device)
LKX
Device Description
Instalief™ is a device designed for the treatment of internal and external hemorrhoids by the application of cold directly to the swollen hemorrhoidal tissue.
The device consists of an outer bag which houses an endothermic salt, a smaller water-containing frangible bag, an insertion tip with an attached compliant balloon, as well as a separate component that aids in the usage of the device, known as the squeezer.
To use the device, the user first bursts the frangible bag by pressing on it, initiating an endothermic process between the water and endothermic salt. The user then inserts the shaft of the device into the anal canal (for internal hemorrhoids) or applies to the outer tissues (for external hemorrhoids), and squeezes the bag with the aid of the squeezer. This action transfers the cold fluid generated into the balloon, which provides targeted cold therapy to the hemorrhoids. Instalief™ is meant to be used for 6 - 8 minutes.
In terms of physical characteristics, Instalief™ is anatomically designed by taking into account human anatomical characteristics. The introducer and balloon, which comes into contact with the user, is made from medical-grade material and conforms to the biocompatibility requirements of the device class. The introducer has filleted edges and a tapered shaft for smooth insertion into the anal. It is also designed with a functional length long enough to reach the internal hemorrhoids, as well as a flared base to physically prevent over-insertion. The balloon dimensions were chosen to allow for safe inflation without compromising the integrity of the material.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
anal canal
Indicated Patient Age Range
adults only
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Testing:
Structural Integrity:
- Inflated Static Load Pull Test - VV0001P: Passed
- Balloon Burst Volume Test - VV0002P: Passed
- Compression Test (Against Predicate) - VV0007P, VV0009P: Both Devices Passed
Functional Performance: - Cold Duration Test (Against Predicate) - VV0003P, VV0008P: Cold duration similar to predicate
Biocompatibility: - In-vitro cytotoxicity – Elution method: Non-cytotoxic
- Skin sensitization test in guinea pigs (guinea pig maximization test): Non-sensitizing
- Intracutaneous reactivity test in New Zealand white rabbits: Non-reactive
Clinical Testing:
Clinical testing is not applicable for establishing substantial equivalence of Instalief™.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
N/A
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
January 10, 2018
Privi Medical Pte Ltd % Alan Donald, MS, MBA, RAC President Matrix Medical Consulting, Inc. 8880 Rio San Diego Drive, Suite 800 San Diego. CA 92108
K172358 Trade/Device Name: Instalief Regulatory Class: Unclassified Product Code: LKX Dated: December 16, 2017 Received: December 19, 2017
Dear Alan Donald:
Re:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
1
(Sections 531-542 of the Act); 21 CFR 1000-1050.
You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Image /page/1/Picture/5 description: The image shows the name "Benjamin R. Fisher -S" in a large, bold font. The text is black and appears to be against a white background. The letters are clearly legible and evenly spaced.
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K172358
Device Name Instalief
Indications for Use (Describe)
Instalief is a single use device for the treatment of hemorrhoids by applying it directly to the sworthoidal tissues. By applying cold to the tissue, the inflammation is reduced. The device can be used for the treatment of external hemorrhoids and internal hemorrhoids. The device is for adults only.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
|X | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Privi Medical Pte Ltd Instalief™ Traditional 510(k) Section 5 - Summary of Safety and Effectiveness
Section 5 - Summary of Safety and Effectiveness
1. Submitter's Information:
Company Name: Privi Medical Pte. Ltd. Company Address: 79 Ayer Rajah Crescent #05-03, Singapore 139955 Company Phone Number: (415) 906-5188 (USA) Contact: Mr. Prusothman M Sina Raja, CEO Establishment Registration Number: Not yet obtained.
Device Trade Name: Instalief™ Common Name: Hemorrhoid Cooling Device Classification Name: Device, Thermal, Hemorrhoids (LKX) Product Code: LKX
2. Authorized Contact Person:
Name: Prusothman M Sina Raja Email: prusothman@privimedical.com, prusothman@gmail.com Telephone: (65) 93393513 (Singapore) / (415) 906-5188 (USA)
3. Company Device Information:
Device Name: Instalief™ Classification: Unclassified (Pre-Amendment)
4. Predicate Device Information:
Device Name: ANUICE Cryotherapy Pain Relief Products, Inc. Classification: Unclassified (Pre-Amendment) 510(k): K981428 Product Code: LKX
5. Submission Information:
Date Summary Prepared: 11th July 2017 Prepared by: Prusothman M Sina Raja
4
6. Device Description
Instalief™ is a device designed for the treatment of internal and external hemorrhoids by the application of cold directly to the swollen hemorrhoidal tissue.
The device consists of an outer bag which houses an endothermic salt, a smaller water-containing frangible bag, an insertion tip with an attached compliant balloon, as well as a separate component that aids in the usage of the device, known as the squeezer.
To use the device, the user first bursts the frangible bag by pressing on it, initiating an endothermic process between the water and endothermic salt. The user then inserts the shaft of the device into the anal canal (for internal hemorrhoids) or applies to the outer tissues (for external hemorrhoids), and squeezes the bag with the aid of the squeezer. This action transfers the cold fluid generated into the balloon, which provides targeted cold therapy to the hemorrhoids. Instalief™ is meant to be used for 6 - 8 minutes.
In terms of physical characteristics, Instalief™ is anatomically designed by taking into account human anatomical characteristics. The introducer and balloon, which comes into contact with the user, is made from medical-grade material and conforms to the biocompatibility requirements of the device class. The introducer has filleted edges and a tapered shaft for smooth insertion into the anal. It is also designed with a functional length long enough to reach the internal hemorrhoids, as well as a flared base to physically prevent over-insertion. The balloon dimensions were chosen to allow for safe inflation without compromising the integrity of the material.
7. Indications for Use
Instalief™ is a single use device for the treatment of hemorrhoids by applying it directly to the swollen hemorrhoidal tissues. By applying cold to the tissue, the inflammation is reduced. The device can be used for the treatment of external hemorrhoids and internal hemorrhoids. The device is for adults only.
8. Substantial Equivalency
Instalief™ is substantially equivalent to Anuice and raises no new safety or effectiveness issues.
8.1. Non-Clinical Testing
The following tests were performed on Instalief™ and the predicate device (where applicable), for the comparison of functional performance and evaluation
5
of both structural integrity and biocompatibility.
| Structural Integrity | |
|---|---|
| Performance Documentation (Test | |
| Protocols) | Summary of Results |
| Inflated Static Load Pull Test |
- VV0001P | Passed |
| Balloon Burst Volume Test - VV0002P | Passed |
| Compression Test (Against Predicate) - VV0007P
- VV0009P | Both Devices Passed |
| Functional Performance | |
| Performance Documentation (Test
Protocols) | Summary of Results |
| Cold Duration Test (Against Predicate) - VV0003P
- VV0008P | Cold duration similar to predicate |
| Biocompatibility | |
| Test Information and Details | Summary of Results |
| In-vitro cytotoxicity – Elution method | Non-cytotoxic |
| Skin sensitization test in guinea pigs (guinea
pig maximization test) | Non-sensitizing |
| Intracutaneous reactivity test in New Zealand
white rabbits | Non-reactive |
8.2. Clinical Testing
Clinical testing is not applicable for establishing substantial equivalence of Instalief™.
8.3. Comparison Table of New and Predicate Device
| Features and Specifications | InstaliefTM | Anuice | Notes | |
|---|---|---|---|---|
| 1 | Mode of action | Application of cold to hemorrhoidal tissue | Application of cold to hemorrhoidal tissue | Same |
| 2 | Max insertion | Up to 25mm into | Up to 45mm into | Smaller initial insertion |
| depth | the anal canal (for | |||
| internal | ||||
| hemorrhoids) | the anal canal (for | |||
| internal | ||||
| hemorrhoids) | depth for Instalief™ | |||
| 3 | Max working | |||
| depth | Up to 55mm into | |||
| the anal canal (for | ||||
| internal | ||||
| hemorrhoids) | Up to 45mm into | |||
| the anal canal (for | ||||
| internal | ||||
| hemorrhoids) | Both depths are in similar | |||
| range. The slightly deeper | ||||
| working depth ensures | ||||
| better coverage of | ||||
| hemorrhoidal region. | ||||
| 4 | Insertion depth | |||
| limiter | Flared base | |||
| component | Flared base | |||
| component | Same. Both designed to | |||
| physically limit insertion | ||||
| depth. | ||||
| 5 | Insertion OD | 7 mm (without | ||
| balloon inflation) | ||||
| 30 mm maximum | ||||
| (with balloon | ||||
| inflation) | 11mm | A smaller insertion OD | ||
| allows for easier and more | ||||
| comfortable insertion and | ||||
| removal. | ||||
| The balloon is expanded | ||||
| after insertion into the anal | ||||
| canal, and is deflated prior | ||||
| to being withdrawn. | ||||
| 6 | Cold source | Chemical | ||
| (endothermic | ||||
| process) | Physical (phase | |||
| change) | Similar. In Instalief™, the | |||
| cold source is generated | ||||
| through an endothermic | ||||
| reaction, while the predicate | ||||
| device achieves this through | ||||
| a physical change of state of | ||||
| its contained substance. | ||||
| Both devices function using | ||||
| the principle of cold | ||||
| therapy. | ||||
| 7 | Shaft material | Silicone Rubber | ||
| (introducer) | Rigid plastic | Soft flexible shaft reduces | ||
| the risk of tissue damage | ||||
| caused by erroneous | ||||
| insertion technique | ||||
| 8 | Cold therapy | |||
| delivery | Delivered via a | |||
| compliant balloon | Delivered via a | |||
| hollow shaft | The balloon is a better cold | |||
| therapy delivery component | ||||
| as it conforms to the shape | ||||
| of the anal canal | ||||
| 9 | Removal | |||
| mechanism | Deflate balloon | |||
| followed by | ||||
| withdrawal | Withdrawal of | |||
| device | Similar | |||
| 10 | Base | PVC Bag | Hard plastic | Bag is designed to |
| withstand the require back | ||||
| pressure during usage (see | ||||
| VV0007P) | ||||
| 11 | Anatomically | |||
| designed | Yes. General design | |||
| characteristics: |
- Tapered shaft
extending into anal
canal - “Base” feature to
prevent over-
insertion of device - Smooth rounded
corners - No sharp edges | Yes. General
design
characteristics: - Tapered shaft
extending into
anal canal - “Base” feature
to prevent over-
insertion of
device - Smooth
rounded corners - No sharp edges | Same. Similar design
characteristics meant to
facilitate insertion
into/removal out of the anal
canal. |
6
Privi Medical Pte Ltd
Instalief™
Traditional 510(k) Section 5 - Summary of Safety and Effectiveness
7
Privi Medical Pte Ltd Instalief™ Traditional 510(k)
Section 5 - Summary of Safety and Effectiveness
- 8.4. Studies Cited for Substantial Equivalence Discussion
- 8.4.1. Ratuapli, M. D. et al.(2013). Comparison of rectal balloon expulsion test in seated and left lateral positions. Neorugastroenterol Motil. 25(12). Doi:10.1111/nmo.12208
- 8.4.2. Padda, B. S. et al. (2006). Effects of pelvic floor muscle contraction on anal canal pressure. Am J Physiol Gastrointest Liver Physiol. 292: G565-G571. Doi:10.1152/ajpgi.00250.2006
- 8.4.3. Duthie, H. L., Bennett, R. C. (1963). The relation of sensation in the anal canal to the functional anal sphincter: a possible factor in anal continence. Gut,4, 179-182. Doi:10.1136/gut.4.2.179
- 8.5. Referenced Devices
- 8.5.1. GelPOINT Path Transanal Access Platform (K133393)
9. Conclusion
Based on the comparison of intended use, indications for use, non-clinical testing, literature, biocompatibility testing and technological characteristics, the Instalief™ is substantially equivalent to Anuice (K981428) and raises no new safety or effectiveness issues.